Még nem toboroz
Multi-center Study of Three-Dimensional Transesophageal Echocardiography in Patients With Secondary Mitral Regurgitation
NCT07918937· First Hospital of China Medical University· Forrás
Contact: Chang Zhou (principal investigator)
Még nem toboroz
Early Lumbar Drainage for Intraventricular Hemorrhage
NCT07625449· Second Affiliated Hospital of Nanchang University· Forrás
Contact: Yichang Central People's Hospital
Toboroz
Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT07687459· 3. fázis· InSilico Medicine Hong Kong Limited· Forrás
Contact: Qinhan Chen
Toboroz
A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
NCT07747857· 1. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Weimin Zhao, Master
Toboroz
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
NCT07687186· 3. fázis· Tasly Pharmaceutical Group Co., Ltd· Forrás
Contact: Lin Teng
Toboroz
Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC
NCT07741448· 2. fázis· Zhiquan Hu· Forrás
Contact: Xiaobo Chen, M.D.
Toboroz
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
NCT07700667· 2. fázis· Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.· Forrás
Contact: Qing Yan
Fut, nem toboroz
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
NCT07662122· 2. fázis· Boehringer Ingelheim· Forrás
Toboroz
A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
NCT07509892· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Xiaoqiang Hou, Master
Toboroz
Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases
NCT07595068· Renmin Hospital of Wuhan University· Forrás
Contact: Zhuli Guo, MD
Toboroz
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NCT07464587· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Fanjun Zeng, Master
Toboroz
To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus
NCT07447986· 2. fázis· Hangzhou Sumgen Biotech Co., Ltd.· Forrás
Contact: Xiaoqiang Hou, Master
Még nem toboroz
Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO)
NCT07469293· 3. fázis· Southwest Hospital, China· Forrás
Contact: Zhou Jinghua
Toboroz
Phase II Trial of RC1416 Injection in Asthma
NCT07403487· 2. fázis· Nanjing RegeneCore Biotech Co., Ltd.· Forrás
Contact: Xiong Xiao Qi
Toboroz
Phase II Study of RC1416 Injection in COPD
NCT07402551· 2. fázis· Nanjing RegeneCore Biotech Co., Ltd.· Forrás
Contact: Xiaoqi Xiong
Még nem toboroz
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE)
NCT07274137· 3. fázis· MindRank AI Ltd· Forrás
Contact: Jun Zeng
Fut, nem toboroz
A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)
NCT07230119· 3. fázis· Beijing QL Biopharmaceutical Co.,Ltd· Forrás
Toboroz
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
NCT07284134· 3. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Contact: Qiao Huang, Doctor
Toboroz
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
NCT07168161· 3. fázis· Staidson (Beijing) Biopharmaceuticals Co., Ltd· Forrás
Contact: Xiaoqiang Hou
Toboroz
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
NCT07208097· Tongji Hospital· Forrás
Contact: Xia Kailai
Toboroz
TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage
NCT07187687· Xuanwu Hospital, Beijing· Forrás
Contact: chunlei tian
Toboroz
Burst Stimulation for Paroxysmal Atrial Fibrillation
NCT07281898· Zhibing Lu· Forrás
Contact: Zhuli Guo
Toboroz
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
NCT07154264· 2. fázis· Dizal Pharmaceuticals· Forrás
Contact: Cai
Toboroz
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07288554· 1. fázis· Bambusa Therapeutics· Forrás
Contact: Xiaoqi Xiong
Még nem toboroz
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NCT07147946· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Contact: Fanjun Zeng, Master
Toboroz
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
NCT07152639· 3. fázis· Chengdu CoenBiotech Co., Ltd· Forrás
Contact: Xi Wei
Toboroz
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035· Union Hospital, Tongji Medical College, Huazhong University of Science and Technology· Forrás
Contact: Yaowei Bai
Toboroz
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT07292714· 2. fázis· Mabwell (Shanghai) Bioscience Co., Ltd.· Forrás
Contact: Yongchang Sun, Doctor
Még nem toboroz
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer
NCT07007286· Peking University First Hospital· Forrás
Contact: Xiaolin Zhou
Toboroz
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
NCT06892548· 1/2. fázis· BioNTech SE· Forrás
Még nem toboroz
A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis
NCT06958861· 2. fázis· Shanghai Huilun Pharmaceutical Co., Ltd.· Forrás
Contact: Xinyu Song
Toboroz
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
NCT06817265· 3. fázis· Beletalent (Zhuhai) Pharmaceutical Co., Ltd· Forrás
Contact: Yan Zhang
Toboroz
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
NCT07128186· Tongji Hospital· Forrás
Contact: Zhaoyang Zeng
Még nem toboroz
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.
NCT06922903· 3. fázis· Yunhe Pharmaceutical (Tianjin) Co., Ltd· Forrás
Contact: Dong Yuan
Még nem toboroz
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment
NCT06922929· 3. fázis· Yunhe Pharmaceutical (Tianjin) Co., Ltd· Forrás
Contact: Dong Yuan
Toboroz
Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer
NCT06889688· 3. fázis· Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University· Forrás
Contact: Yuyan Tan, M.D., Ph.D.
Fut, nem toboroz
A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT06707883· 2. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás
Toboroz
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
NCT06532006· 3. fázis· Shanghai Henlius Biotech· Forrás
Contact: Ying Li
Fut, nem toboroz
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)
NCT06559241· 3. fázis· Capital Medical University· Forrás
Contact: Huajun Zhou
Toboroz
Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
NCT07356531· JIANGSU SHENMING Medical Technology CO., Ltd· Forrás
Contact: Cui Chen, chief physician
Toboroz
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
NCT06431490· 1/2. fázis· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Forrás
Contact: Cui Chen, Master
Fut, nem toboroz
Efficacy and Safety of Colchicine After PCI
NCT06472908· 3. fázis· Union Hospital, Tongji Medical College, Huazhong University of Science and Technology· Forrás
Fut, nem toboroz
SIM0718 Treatment of Asthma Clinical Study
NCT06488755· 3. fázis· Simcere Pharmaceutical Co., Ltd· Forrás
Toboroz
ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)
NCT06378138· 2/3. fázis· Beijing InnoCare Pharma Tech Co., Ltd.· Forrás
Contact: Huili Cai
Fut, nem toboroz
A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer
NCT06984588· 2/3. fázis· TJ Biopharma Co., Ltd.· Forrás
Toboroz
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
NCT06119581· 3. fázis· Eli Lilly and Company· Forrás
Contact: Xinhua Xu (principal investigator)
Fut, nem toboroz
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
NCT05365178· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Fut, nem toboroz
PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer
NCT05180734· 3. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Fut, nem toboroz
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT04965493· 3. fázis· Loxo Oncology, Inc.· Forrás
Showing 50 of 51.